Magnetite graphene oxide-albumin conjugate: carrier for the imatinib anticancer drug.
Journal
Journal of materials science. Materials in medicine
ISSN: 1573-4838
Titre abrégé: J Mater Sci Mater Med
Pays: United States
ID NLM: 9013087
Informations de publication
Date de publication:
14 Jul 2023
14 Jul 2023
Historique:
received:
21
01
2023
accepted:
19
06
2023
medline:
17
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
Carbon nanomaterials are widely used in biomedical applications due to their versatile properties. These are the attractive candidates for the carrying of anticancer drugs, genes, and proteins for chemotherapy. Imatinib is an effective chemotherapy drug whose toxicity has created a significant limitation in treatment. In this research, a new biocompatible nanocarrier based on albumin-magnetite graphene oxide conjugates was reported for the loading and release of imatinib. The magnetite graphene oxide nanocomposite was investigated by ultra violet-visible spectroscopy (UV-Vis), field emission scanning electron microscope (FE-SEM), X-ray diffraction spectroscopy (XRD) and energy diepersive X-ray spectroscopy (EDX) methods. The crystallite size of Fe
Identifiants
pubmed: 37450082
doi: 10.1007/s10856-023-06735-1
pii: 10.1007/s10856-023-06735-1
pmc: PMC10348929
doi:
Substances chimiques
Imatinib Mesylate
8A1O1M485B
Ferrosoferric Oxide
XM0M87F357
Drug Carriers
0
graphene oxide
0
Antineoplastic Agents
0
Graphite
7782-42-5
Albumins
0
Magnetite Nanoparticles
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
32Informations de copyright
© 2023. The Author(s).
Références
Pandit R, Chen L, Götz J. The blood-brain barrier: physiology and strategies for drug delivery. Adv Drug Deliv Rev. 2020;165:1–14.
doi: 10.1016/j.addr.2019.11.009
Li C, Wang J, Wang Y, Gao H, Wei G, Huang Y, et al. Recent progress in drug delivery. Acta Pharm Sin B. 2019;9:1145–62.
doi: 10.1016/j.apsb.2019.08.003
Amiri M, Khazaeli P, Salehabadi A, Salavati-Niasari M. Hydrogel beads-based nanocomposites in novel drug delivery platforms: recent trends and developments. Adv Colloid Interface Sci. 2021;288:102316.
doi: 10.1016/j.cis.2020.102316
Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20:101–24.
doi: 10.1038/s41573-020-0090-8
Rezaeifar M, Mahmoudvand H, Amiri M. Formulation and evaluation of diphenhydramine gel using different gelling agents. Der Pharma Chem. 2016;8:243–9.
Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018;3:1–19.
Zhao Z, Ukidve A, Kim J, Mitragotri S. Targeting strategies for tissue-specific drug delivery. Cell. 2020;181:151–67.
doi: 10.1016/j.cell.2020.02.001
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16:1–33.
doi: 10.1186/s12951-018-0392-8
Amiri M, Gholami T, Amiri O, Pardakhti A, Ahmadi M, Akbari A, et al. The magnetic inorganic-organic nanocomposite based on ZnFe
doi: 10.1016/j.jallcom.2020.156604
Hui Y, Yi X, Hou F, Wibowo D, Zhang F, Zhao D, et al. Role of nanoparticle mechanical properties in cancer drug delivery. ACS Nano. 2019;13:7410–24.
doi: 10.1021/acsnano.9b03924
Begines B, Ortiz T, Pérez-Aranda M, Martínez G, Merinero M, Argüelles-Arias F, et al. Polymeric nanoparticles for drug delivery: Recent developments and future prospects. Nanomater. 2020;10:1403.
doi: 10.3390/nano10071403
Sharma H, Mondal S. Functionalized graphene oxide for chemotherapeutic drug delivery and cancer treatment: a promising material in nanomedicine. Int J Mol Sci. 2020;21:6280.
doi: 10.3390/ijms21176280
Shafiee A, Iravani S, Varma RS. Graphene and graphene oxide with anti-cancer applications: challenges and future perspectives. MedComm. 2022;3:e118.
doi: 10.1002/mco2.118
Daniyal M, Liu B, Wang W. Comprehensive review on graphene oxide for use in drug delivery system. Curr Med Chem. 2020;27:3665–85.
doi: 10.2174/13816128256661902011296290
Orooji Y, Khojasteh H, Amiri O, Amiri M, Hasanifard S, Khanahmadzadeh S, et al. A combination of hydrothermal, intercalation and electrochemical methods for the preparation of high-quality graphene: characterization and using to prepare graphene-polyurethane nanocomposite. J Alloy Compd. 2020;848:156495.
doi: 10.1016/j.jallcom.2020.156495
Ghawanmeh AA, Ali GA, Algarni H, Sarkar SM, Chong KF. Graphene oxide-based hydrogels as a nanocarrier for anti-cancer drug delivery. Nano Res. 2019;12:973–90.
doi: 10.1007/s12274-019-2300-4
Liu J, Fu S, Yuan B, Li Y, Deng Z. Toward a universal “adhesive nanosheet” for the assembly of multiple nanoparticles based on a protein-induced reduction/decoration of graphene oxide. J Am Chem Soc. 2010;132:7279–81.
doi: 10.1021/ja100938r
Akbari H, Askari E, Naghib SM, Salehi Z. Bovine serum albumin-functionalized graphene-decorated strontium as a potent complex nanoparticle for bone tissue engineering. Sci Rep. 2022;12:12336.
doi: 10.1038/s41598-022-16568-7
Ahadian S, Estili M, Jayaraman Surya V, Ramon-Azcon J, Liang X, Shiku H, et al. Facile and green production of aqueous graphene dispersions for biomedical applications. Nanoscale. 2015;7:6436–43.
doi: 10.1039/C4NR07569B
Buclin T, Thoma Y, Widmer N, André P, Guidi M, Csajka C, et al. The steps to therapeutic drug monitoring: a structured approach illustrated with imatinib. Front Pharmacol. 2020;11:177.
doi: 10.3389/fphar.2020.00177
Hosseini M, Amiri M, Ghanbari M, Mahdi MA, Abdulsahib WK, Salavati-Niasari M. Drug delivery based on chitosan, β-cyclodextrin and sodium carboxymethyl cellulose as well as nanocarriers for advanced leukemia treatment. Biomed Pharmacother. 2022;153:113369.
doi: 10.1016/j.biopha.2022.113369
Hochhaus A, Larson RA, Guilhot F, Radich JP, Branford S, Hughes TP, et al. Long-term outcomes of imatinib treatment for chronic myeloid leukemia. J Med. 2017;376:917–27.
Bagheri Ladmakhi H, Chekin F, Fathi SH, Raoof JB. Electrochemical sensor based on magnetite graphene oxide/ordered mesoporous carbon hybrid to detection of allopurinol in clinical samples. Talanta. 2020;211:120759.
doi: 10.1016/j.talanta.2020.120759
Hazhir N, Chekin F, Raoof JB. Fathi Sh A porous reduced graphene oxide/chitosan-based nanocarrier as a delivery system of doxorubicin. RSC Adv. 2019;9:30729–35.
doi: 10.1039/C9RA04977K
Samimi Tehrani N, Masoumi M, Chekin F, Sharifzadeh Baei M. Nitrogen doped porous reduced graphene oxide hybrid as a nanocarrier of imatinib anti-cancer drug. Russ J Appl Chem. 2020;93:1221–8.
doi: 10.1134/S1070427220080157
Zareyy B, Chekin F, Fathi SH. NiO/porous reduced graphene oxide as active hybrid electrocatalyst for oxygen evolution reaction. Russ J Electrochem. 2019;55:333–8.
doi: 10.1134/S102319351903011X
Nikkhah SH, Tahermansouri H, Chekin F. Synthesis, characterization, and electrochemical properties of the modified graphene oxide with 4,4׳-methylenedianiline. Mater Lett. 2018;211:323–7.
doi: 10.1016/j.matlet.2017.10.037
Vatandost E, Ghorbani-HasanSaraei A, Chekin F, Naghizadeh Raeisi SH, Shahidi SA. Electrochemical sensor based on magnetic Fe
doi: 10.1134/S102319352105013X
Zhou Y, Zhao X, Liu F, Chi W, Yao J, Chen G. Facile one-pot solvothermal synthesis of the RGO/MWCNT/Fe
doi: 10.1021/acsomega.9b03740
Chaki SH, Malek TJ, Chaudhary MD, Tailor JP, Deshpande MP. Magnetite Fe
doi: 10.1088/2043-6262/6/3/035009